Growth Metrics

Pfizer (PFE) Pension (2016 - 2025)

Pfizer (PFE) has disclosed Pension for 17 consecutive years, with $2.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Pension fell 3.5% to $2.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 billion, a 3.5% decrease, with the full-year FY2025 number at $2.0 billion, down 3.5% from a year prior.
  • Pension was $2.0 billion for Q4 2025 at Pfizer, down from $2.2 billion in the prior quarter.
  • In the past five years, Pension ranged from a high of $3.7 billion in Q4 2021 to a low of $233.0 million in Q2 2022.
  • A 5-year average of $2.1 billion and a median of $2.1 billion in 2025 define the central range for Pension.
  • Peak YoY movement for Pension: tumbled 88.33% in 2021, then surged 835.19% in 2023.
  • Pfizer's Pension stood at $3.7 billion in 2021, then crashed by 39.58% to $2.2 billion in 2022, then decreased by 3.69% to $2.2 billion in 2023, then dropped by 2.4% to $2.1 billion in 2024, then fell by 3.5% to $2.0 billion in 2025.
  • Per Business Quant, the three most recent readings for PFE's Pension are $2.0 billion (Q4 2025), $2.2 billion (Q3 2025), and $2.1 billion (Q2 2025).